Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV epidemiology: past, present, and future.

W A Blattner1

  • 1Viral Epidemiology Section, National Cancer Institute, Bethesda, Maryland 20892.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|July 1, 1991
PubMed
Summary

The human immunodeficiency virus (HIV-1) causes acquired immunodeficiency syndrome (AIDS), a global pandemic with long-term health impacts. Antiretroviral therapy shows promise, but new treatments and an HIV vaccine are crucial research priorities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune status, and not HIV infection or exposure, drives the development of the oral microbiota.

Scientific reports·2020
Same author

HIV-1 Antiretroviral Drug Resistance in Pregnant Women in Jamaica: A Preliminary Report.

The West Indian medical journal·2015
Same author

HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.

Mucosal immunology·2013
Same author

Adherence to anti retroviral therapy (ART) during Muslim Ramadan fasting.

AIDS and behavior·2008
Same author

Immunologic and virologic analyses of an acutely HIV type 1-infected patient with extremely rapid disease progression.

AIDS research and human retroviruses·2001
Same author

Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody.

Journal of clinical microbiology·2001

Area of Science:

  • Virology
  • Immunology
  • Epidemiology

Background:

  • The global acquired immunodeficiency syndrome (AIDS) pandemic, caused by human immunodeficiency virus type 1 (HIV-1), poses significant long-term medical and social challenges.
  • HIV-1 is a lentiretrovirus transmitted through blood and bodily fluids, leading to progressive depletion of CD-4 T lymphocytes and immune system compromise.
  • The World Health Organization estimates millions are currently infected, with projections indicating a substantial increase into the 21st century.

Purpose of the Study:

  • To highlight the ongoing global impact of HIV-1 and AIDS.
  • To emphasize the role of antiretroviral therapy in managing HIV-1 infection.
  • To underscore the urgent need for further therapeutic development and an effective HIV vaccine.

Main Methods:

Related Experiment Videos

  • Review of current epidemiological data on HIV-1 infection and AIDS incidence.
  • Analysis of the natural history of HIV-1 infection, including incubation periods and immunological effects.
  • Assessment of the impact of antiretroviral therapy on disease progression and incidence.

Main Results:

  • Antiretroviral therapy has contributed to a leveling off of AIDS incidence in some regions, demonstrating therapeutic benefits.
  • Prolonged survival due to therapy may lead to other long-term complications like cancer and lymphoma.
  • The substantial number of infected individuals and ongoing viral spread necessitate continued research.

Conclusions:

  • HIV-1 remains a critical global health concern requiring sustained medical research efforts.
  • Wider access to existing antiretroviral therapies could yield significant public health benefits.
  • The development of novel therapies and a preventative HIV vaccine are paramount priorities.